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Abstract  The  haemangioma,  the  most  common  non-cystic  hepatic  lesion,  most  often  discov-
ered by  chance,  may  in  certain  situations  raise  diagnostic  problems  in  imaging.  In  this  article,
the authors  ﬁrst  demonstrate  that  the  radiological  appearance  of  the  hepatic  haemangioma,
in its  typical  form,  is  closely  related  to  three  known  histological  sub-types.  They  then  show
that certain  atypical  features  should  be  known  in  order  to  establish  a  diagnosis.  They  also
observe the  potential  interactions  between  the  haemangioma,  an  active  vascular  lesion,  and  the
adjacent  hepatic  parenchyma.  Finally,  they  discuss  the  speciﬁc  paediatric  features  of  hepatic
haemangiomas  and  illustrate  the  case  of  a  hepatic  angiosarcoma.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Detected  by  chance  in  most  cases,  the  hepatic  haemangioma  is  the  most  common  non-
cystic  hepatic  lesion.  The  incidence  may  reach  20%  according  to  several  autopsy  series
[1].
In  its  typical  form,  the  haemangioma  is  well  known  and  does  not  raise  diagnostic
problems  in  imaging.  However,  certain  ‘‘variants’’  and  ‘‘atypias’’  may  complicate  the
diagnosis.
The  hepatic  haemangioma  is  a  benign  vascular  lesion.  In  the  vast  majority  of  cases,  it
is  non-evolving  and  does  not  require  treatment  or  monitoring.
Histologically,  it  is  a  mesenchymal  lesion  consisting  of  blood-ﬁlled  vascular  cavities  of
different  size,  surrounded  by  a  simple  layer  of  ﬂat  endothelial  cells,  supported  by  a  ﬁbrous
connective  tissue  [2].
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The  purpose  of  this  iconographic  review  is  to  call  to  mind
he  classic  radiological  aspects  of  the  hepatic  haemangi-
ma  and  the  different  atypical  forms  that  this  lesion  may
ave.  The  potential  interactions  between  the  haemangioma
nd  the  adjacent  hepatic  parenchyma  are  also  discussed.
inally,  the  speciﬁc  paediatric  features  of  hepatic  haeman-
iomas  are  presented,  illustrated  by  the  case  of  a hepatic
ngiosarcoma.
ypical aspects
n  its  typical  form,  three  histological  sub-types  have  been
escribed:  the  capillary  haemangioma,  the  cavernous  haem-
ngioma  and  the  sclerosing  haemangioma,  united  by  a
ommon  lesional  continuum.
avernous haemangioma
he  cavernous  haemangioma  is  the  most  common  histolog-
cal  sub-type  and  corresponds  to  the  classic  semiological
escription  of  the  haemangioma  in  imaging.
This  is  a  lesion  consisting  of  large  vascular  spaces  with
 central  cavernous  zone,  all  the  larger  with  a  voluminous
aemangioma,  and  not  very  extensive  connective  tissue  [3].
In  general,  this  typical  appearance  is  observed  in  lesions
ess  than  3  cm  in  diameter  [4].  The  outlines  are  sharp,  well
eﬁned.
In  the  sonograph,  it  is  a  hyperechogenic,  homogenous
esion  presenting  a  posterior  acoustic  enhancement.  Accord-
ng  to  Yu  et  al.,  there  is  a  correlation  between  the
chogenicity  of  the  lesion,  its  internal  architecture  and
ts  haemodynamic  behaviour  [5].  Therefore,  the  hypere-
hogenicity  of  cavernous  haemangiomas  seem  to  be  related
o  the  great  many  interfaces  between  the  vascular  spaces
nd  the  ﬁbrous  stoma  as  well  as  to  the  slower  blood  ﬂow  in
he  large  vascular  spaces  [5].
In  unenhanced  CT,  the  density  of  the  lesion  is  the  same
s  that  of  the  vessels.
In  MRI,  the  lesion  presents  an  homogenous  and  high
ntensity  signal  on  T2-weighted  images  (similar  to  that
f  the  cerebrospinal  ﬂuid),  a  low  intensity  signal  on  T1-
eighted  images  and  the  absence  of  restriction  of  the
pparent  diffusion  coefﬁcient  (ADC),  with  mean  values
uch  higher  than  that  of  the  hepatic  parenchyma  and  ran-
ing  from  1.69  ×  10−3 mm2/s  (±  0.34  ×  10−3 mm2/s)  [6]  to
.36  ×  10−3 mm2/s  (±  0.48  ×  10−3 mm2/s)  [7]  according  to
he  gradient  values  (b)  used  (Fig.  1a).
The  enhancement  kinetics  is  slow.  Classically,  a  nodu-
ar  peripheral  enhancement  is  observed,  as  well  as  late,
rogressive,  centripetal,  full  and  persistent  ﬁlling  [3]. This
nhancement  kinetics  is  also  observed  by  contrast  sonogra-
hy  and  is  reproducible  and  speciﬁc  (Fig.  1b)  [8]. At  the
rterial  time,  ‘‘bridged’’  contrast  enhancement  crossing
he  lesion  may  be  associated  with  early  peripheral  contrast
nhancement  (Fig.  1c)  [8].
According  to  Yamashita  et  al.  [9],  the  haemodynamic
ehaviour  of  haemangiomas  depends  on  their  inner  struc-
ure  and,  in  particular,  on  the  size  of  the  vascular  spaces.
herefore,  in  cavernous  haemangiomas,  the  diameters  of
he  vascular  spaces  are  signiﬁcantly  smaller  in  the  early
t
l
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eripheral  zones  of  enhancement  in  clusters  compared  with
he  central  zone  of  progressive  centripetal  ﬁlling  [9].
apillary haemangioma
lso  known  as  fast-ﬂow  haemangioma,  the  capillary  haem-
ngioma  presents  small  vascular  spaces  and  extensive
onnective  tissue  [3].  This  form  accounts  for  16%  of  all  hae-
angiomas  [4]. It  often  consists  of  small  lesions.  According
o  Hanafusa  et  al.  [10],  42%  of  these  haemangioma  are  under
 cm  in  diameter.
In  sonography,  these  haemangioma  are  most  often  hypoe-
hogenic  and  homogenous.  This  hypoechogenicity  seems  to
e  related  to  a predominant  ﬁbrous  stroma  as  well  as  to  a
ast  blood  ﬂow  within  the  reduced  vascular  spaces,  leading
o  less  reverberation  of  the  echoes  [5]. In  the  color  doppler,
t  is  possible  to  observe  an  intra-lesional  ﬂow  [4].
In  CT,  these  small  haemangiomas  appear  to  be  slightly
ypodense  without  injection.  The  density  is  similar  to  that
f  the  aorta  but  they  may  also  be  isodense  and  therefore
ometimes  not  detectable  [11].
The  enhancement  kinetics  is  rapid.  An  early,  intense,
omogeneous  contrast  is  observed  ‘‘by  ﬂash’’,  similar  to
he  aortic  enhancement  in  the  arterial  phase  [1].  Late,  this
nhancement  follows  that  of  the  aorta,  without  washing  [1],
n  particular  distinguishing  the  haemangioma  from  hepato-
ellular  carcinoma  and  certain  hypervascular  metastases.
ccording  to  Yamashita  et  al.,  this  enhancement  dynamics
s  related  to  the  presence  of  small  vascular  spaces,  the  size
f  which  is  similar  to  that  of  the  peripheral  zones  of  cluster
nhancement  [9].
In  MRI,  these  small  lesions  also  present  an  homogenous
nd  high  intensity  signal  on  T2-weighted  images  as  well  as
 contrast  kinetics  similar  to  that  seen  in  X-ray  computed
omography  with  a  uniform  and  rapid  enhancement  [12].
The  association  with  an  arterioportal  shunt  is  common.
n  this  case,  there  is  a  transient  perilesional  enhancement
Fig.  2) [13].
clerosed haemangioma
ertain  haemangioma  may  degenerate  with  an  extensive
brosis  beginning  at  the  centre  of  the  lesion  at  the  origin
f  the  obliteration  of  the  vascular  spaces.  This  is  also  called
 thrombosed  or  hyalinised  haemangioma  [14].
The  criteria  indicating  the  diagnosis  of  sclerosed  haem-
ngioma  are  the  geography  map  appearance  associated  with
 reduction  in  the  volume  of  the  hepatic  parenchyma  with
apsular  retraction.  Lesional  heterogeneity  may  also  exist
ith  the  presence  of  cystic,  haemorrhagic  or  ﬁbrous  patches
14].
In  sonography,  it  consists  of  a  globally  heterogeneous
esion  with  hypoechogenic  zones  that  may  correspond  to
clerotic  zones  in  histology  [14].
In  CT,  focal  nodular  focal  patches  are  observed  that  are
ore  spontaneously  hypodense  than  the  rest  of  the  lesion,
lso  corresponding  to  sclerotic  zones  [15].
In  MRI,  on  T2-weighted  images,  signal  is  heterogeneous,
he  zones  of  central  sclerosis  appear  in  hypointense.
The  enhancement  kinetics  is  slow  with  a  peripheral  nodu-
ar  enhancement,  similar  to  the  cavernous  haemangioma,
ut  with  full  and  very  late  progressive  ﬁlling.  In  fact,  the
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Figure 1. Cavernous haemangioma. a: MRI axial section, diffusion-weighted image with b800 (on the left) and ADC map (on the right): per-
sistent homogenous hyperintense signal without restriction of absence of restriction of the apparent diffusion coefﬁcient (1.74.10−3 mm2/s);
b: contrast sonography: peripheral contrast enhancement at arterial time (b1) with progressive centripetal ﬁlling (b2); c: MRI axial section
dynamic T1-weighted image during hepatic artery phase after gadopentate dimeglumine administration: peripheral contrast enhancement
with ‘‘bridged’’ contrast enhancement crossing the lesion (also visible on Fig. b).
Figure 2. Capillary haemangioma. a: axial T2-weighted MR image: homogenous hyperintense centrimetric lesion; b: axial dynamic T1-
weighted MR image during hepatic arterial phase: ‘‘ﬂash’’ contrast enhancement associated with transitory less intense and poorly deﬁned
perilesional enhancement; c: MRI axial section dynamic-weighted image during portal venous phase: persistence of the homogeneous lesional
contrast enhancement and disappearance of the perilesional enhancement.
8e
e
s
l
i
s
[
e
V
G
I
i
t
t
o
m
z
m
b
l
t
M
F
t
i
ﬁ
t52  
nhancement  of  the  central  scar,  sometimes  obtained  sev-
ral  hours  after  the  injection,  is  inconstant.  Sometimes,
clerosed  haemangiomas  may  not  be  enhanced  at  all,  even
ate.  In  addition,  there  is  classically  an  early  transient  per-
lesional  enhancement  (Fig.  3).  The  diagnosis,  cautiously
uggested  by  the  imaging,  most  often  remains  histological
14].
Table  1  presents  the  different  characteristics  of  cav-
rnous,  capillary  and  sclerosed  haemangiomas.
ariants and atypies
iant haemangiomat  consists  of  a  cavernous  haemangioma  measuring  over  4  cm
n  diameter  [4].  These  haemangiomas  may  be  the  seat  of
hrombosis,  liquefaction  and  ﬁbrosis.  A  cystic  cavity  or  cen-
ral  calciﬁcations  may  appear.  Internal  septa  are  classically
T
h
o
i
igure 3. Sclerosed haemangioma. a: Unenhanced CT, axial section: c
he retraction of the opposite hepatic capsule; b: Contrast-enhanced CT d
n ring, visualization of an afferent artery; c: Contrast-enhanced CT du
lling; d: microscopic appearance with low magniﬁcation (×40) showing
hrombi, separated by a connective tissue presenting hyaline rearrangemT.  Klotz  et  al.
bserved.  The  edges  are  regular  without  loss  of  parenchy-
ateous  volume  or  capsular  retraction.
In  sonography,  this  lesion  seems  to  be  heterogeneous.
In  CT-scan,  a  heterogeneous,  more  hypodense  central
one  may  be  seen.
In  MRI,  the  hyperintensity  on  T2-weighted  images  may  be
odiﬁed  by  the  presence  of  a  hypointense  central  scar.
The  enhancement  kinetics  of  giant  haemangiomas  is  slow
ut  identical  to  that  of  cavernous  haemangiomas  with  nodu-
ar  peripheral  enhancement  followed  by  centripetal  ﬁlling
hat  often  remains  incomplete  [4]  (Fig.  4).
ultiple haemangiomashis  consists  of  several  haemangiomas  distributed  in  the
epatic  parenchyma.  The  haemangiomas  are  multiple  in  10%
f  the  cases  and  most  often  present  a  typical  appearance  in
maging  [4].
entral punctiform calciﬁcations evocative of pheboliths. Also note
uring arterial phase, axial section: early perilesional enhancement
ring portal venous phase, sagittal section: progressive centripetal
 a proliferation of vessels with thick walls containing endoluminal
ents.
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Table  1  Characteristics  of  the  typical  appearance  of  the  three  histological  forms  of  hepatic  haemangiomas.
Capillary  haemangioma  Cavernous  haemangioma  Sclerosed  haemangioma
Histological  composition  Reduced  vascular  spaces  Large  vascular  spaces  Extensive  beginning  ﬁbrosis
at  the  centre  of  the  lesion
Extensive  connective  tissue  Not  very  extensive
connective  tissue
Size  Small  size  (in  general  <  1  cm) Lesion  <  3  cm  =  typical
appearance
Average  size  (3.7  cm  on  the
average)
Giant  >  4  cm
Morphology  Nodular,  homogenous  Well  deﬁned,  internal
septa
Geography  map  appearance,
central  scar,  capsular
retraction,  punctiform
calciﬁcations
Echogenicity  Hypoechogenic,  homogenous  Hyperechogenic,
homogenous
Heterogeneous,
hypoechogenic  centre
Posterior  enhancement  Posterior  enhancement
MRI:  T2-weighted  images  Hyperintense,  homogenous  Hyperintense,
homogenous
Heterogeneous,  peripheral
hyperintense,  central
hypointense
Kinetics  of  the  contrast
enhancement
Rapid  ﬂow,  early
enhancement,  intense,  in
ﬂash,  persistent  at  late  time
Slow  ﬂow,  nodular
peripheral  enhancement,
progressive  and  complete
centripetal  ﬁlling
Slow  ﬂow,  peripheral  nodular
enhancement,  very  late
homogeneous  ﬁlling  (3  h)
Perilesional  environment  Transitory  zone  of
perilesional  enhancement,
Enhancement  in  perilesional
ring,  capsular  retraction
p
d
harterioportal  shunt
Haemangiomatosis
Haemangiomatosis  is  rare  and  asymptomatic  in  the  adult.
It  is  more  often  found  in  the  child  where  it  may  be  associ-
ated  with  congestive  heart  failure  [4].  The  lesions  are  large,
poorly  deﬁned,  conﬂuent,  replacing  almost  all  of  the  hepatic
r
m
(
Figure 4. Giant haemangioma. a: MR axial T2-weighted image: presenc
portal venous phase: nodular peripheral enhancement.arenchyma.  In  the  sonograph,  the  masses  are  poorly
elimited  and  difﬁcult  to  distinguish  from  the  adjacent
epatic  parenchyma.  In  MRI,  the  T1  and  T2-weighted  signal
emains  characteristic.  The  typical  peripheral  enhancement
ay  be  absent  and  only  late  acquisitions  are  informative
Fig.  5)  [4].
e of internal septa; b: dynamic T1-weighted MR axial image during
854  T.  Klotz  et  al.
F large
p  porta
P
T
e
l
a
b
T
c
a
h
C
C
p
o
h
A
a
H
T
s
T
m
F
d
wigure 5. Haemangiomatosis. a: axial T2-weighted MR image: 
olylobulated contours; b: axial T1-weighted dynamic MR image at
edunculated haemangioma
he  pedunculated  haemangioma  is  a  very  rare  lesion  with
xtrahepatic  development.  It  is  well  delimited,  encapsu-
ated,  attached  to  the  liver  by  a  thin  pedicle  that  is  not
lways  visible  in  imaging  [16].  Multi-plane  reformatting  may
e  of  use  to  conﬁrm  the  hepatic  origin  of  the  lesion  (Fig.  6).
he  literature  provides  several  cases  of  volvulus,  a  speciﬁc
omplication  of  pedunculated  haemangioma,  revealed  by
n  acute  abdominal  picture  complicated  with  necrosis  or
aemorrhage  [16].alciﬁed haemangioma
alciﬁcations  are  rare,  punctiform  and  are  either  central  or
eripheral.  They  attest  to  the  presence  of  phleboliths,  most
c
s
s
s
igure 6. Pedunculated haemangioma of the round ligament. a: Contr
eﬁned lesion with slight enhancement; b: Contrast-enhanced CT during 
ith mass effect on the left lobe; c: sonography: hyperechogenic, heter conﬂuent masses in heterogeneous hyperintense and presenting
l venous phase: nodular peripheral enhancement.
ften  visible  in  sclerosed  haemangiomas  or  giant  reshaped
aemangiomas  (Figs.  3  and  9) [4].
ssociated adjacent parenchymateous
nomalies
aemangioma with arterioportal shunt
he  association  of  a  haemangioma  and  an  arterioportal
hunt  is  reported  with  an  incidence  of  up  to  26%  [13].
his  association  is  signiﬁcantly  more  common  with  hae-
angiomas  with  fast  enhancement  kinetics  [13],  that  is,
apillary  haemangiomas.  The  presence  of  transient  perile-
ional  enhancement  is  signiﬁcantly  more  common  with  a
mall  haemangioma  (<  2  cm)  than  with  a  HCC  of  the  same
ize  [17].
ast-enhanced CT during portal venous phase, coronal section: well
the equilibrium phase, axial section: seemingly extrahepatic lesion
ogeneous appearance with posterior enhancement.
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With  color  doppler,  it  is  possible  to  visualise  the  afferent
arterial  ﬂow  and  the  efferent  portal  ﬂow.
After  injection,  this  shunt  provokes  the  early  opaciﬁca-
tion  of  the  adjacent  portal  branches  (Fig.  7)  [18].
Haemangioma associated with focal nodular
hyperplasia
This  consists  of  a  relatively  common  association  involving
about  20%  of  all  patients  with  focal  nodular  hyperplasia  [19].
This  association  is  also  more  often  noted  in  cases  of  multiple
focal  nodular  hyperplasia  and  in  case  of  treatment  with  oral
contraceptives  [20].  In  fact,  nodular  and  focal  hyperplasia
is  a  hyperplastic  response  to  the  focal  increase  in  the  arte-
rial  ﬂow  potentially  generated  by  a  haemangioma  [4]. When
these  lesions  maintain  a  typical  appearance  in  imaging,  the
diagnosis  does  not  require  histological  proof  (Fig.  8)  [4].
H
A
t
Figure 7. Haemangioma with arterioportal shunt and hepatic steatos
a hyperechogenic hepatic parenchyma related to diffuse steatosis; b: O
overload with drop in the signal of the rest of the hepatic parenchyma; 
of the afferent artery and early opaciﬁcation of a left segmental portal b
CT during arterial phase: axial section: early and intense lesional enhancs  855
aemangioma with capsular retraction
lthough  often  associated  with  malignant  tumours,  hepatic
apsular  retraction  is  not  formally  a  criterion  indicative  of
alignancy.  In  fact,  it  is  present  when  there  is  a  marked
ocal  ﬁbrous  stroma  reaction  as  in  the  sclerosed  haeman-
iomas.  This  ﬁbrous  reaction  is  the  cause  of  a  progressive
eduction  in  the  size  of  the  haemangioma  resulting  in  a  cap-
ular  retraction  that  is  all  the  more  marked  if  the  lesion  is
ub-capsular  [21]. In  the  series  by  Doyle  et  al.,  70%  of  the
clerosed  haemangiomas  presented  capsular  retraction  or
oncavity  (Figs.  3  and  9) [14].aemangiomas and dilation of the bile duct
 haemangioma  may  exceptionally  induce  the  dilation  of
he  bile  duct,  in  particular  if  it  is  located  in  segment  IV  or
is. a: sonography: hypoechogenic, heterogenic nodular lesion on
ut-of-phase T1-weighted MR image: zone free of perilesional fat
c: dynamic T1-weighted image during arterial phase: visualization
ranch attesting to the presence of the shunt; d: Contrast-enhanced
ement and perilesional parenchymateous enhancement.
856  T.  Klotz  et  al.
Figure 8. Haemangiomas (white arrows) and focal nodular hyperplasias (black arrows). a: Axial dynamic T1-weighted MR image during
arterial phase: haemangioma of segment V next to a large FNH presenting a central scar; b: Axial dynamic T1-weighted MR image during
arterial phase, same patient: on the ungerlying sections, there is a second haemangioma of segment VI next to a second FNH.
Figure 9. Sclerosed haemangioma at the origin of dilation of the segmental bile ducts upstream. a: Contrast-enhanced CT during portal
venous phase, coronal section: punctiform central calciﬁcations and capsular retraction; b: axial T2-weigted MR image: heterogenous
hyperintense with presence of a large area of liquid rearrangement; c: Axial dynamic T1-weighed MR image during portal phase: dilation of
the intrahepatic bile ducts upstream from the lesion; d: bili-MRI 3D sequence, reconstruction in the axial plane: dilation of the intrahepatic
bile ducts of VII (arrow) upstream from the compression exerted by the lesion.
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close  to  the  hepatic  hilium  [22].  This  compressive  appear-
ance,  classically  found  in  all  malignant  tumours,  should  call
into  question  the  diagnosis  of  haemangioma,  outside  of  a
perfectly  characteristic  appearance  (Fig.  9) [22].
Haemangiomas and diffuse liver disease
Haemangioma and hepatic steatosis
Hepatic  steatotic  inﬁltration  is  known  to  modify  the  typi-
cal  appearance  of  focal  hepatic  lesions.  In  sonography,  the
haemangioma  may  appear  slightly  hyperechogenic,  isoe-
chogenic  or  often  hypoechogenic  (Fig.  7)  with  respect  to
the  steatotic  liver  [23].  It  may  maintain  a  posterior  acoustic
enhancement  [4].
In  unenhanced  CT,  the  lesion  may  be  hyperdense  or  iso-
dense  and  not  visible  [4].
In  MRI,  the  hyperintensity  on  T2-weighted  images  is  not
modiﬁed  by  the  hepatic  steatosis.
The  enhancement  kinetics  in  CT  or  MRI  is  not  modiﬁed  by
the  hepatic  steatosis  [24].
A  perilesional  zone  is  often  observed  that  is  free  of  fat
inﬁltration.  This  is  due  to  the  arterioportal  shunt  with  pref-
erential  arterial  vascularisation.  This  appearance  is  often
seen  with  fast  circulation  haemangiomas  [25].  In  sonogra-
phy,  this  zone  is  visible  by  a  perilesional  hypoechogenic  ring
[25].  In  CT-scan,  it  is  seen  in  the  form  of  annular  hyper-
density  in  spontaneous  contrast.  In  MRI,  this  zone  does  not
present  a  drop  in  signal  on  out-of-phase  T1-weighted  image
(Fig.  7)  [17,25].
Haemangioma and cirrhosis of the liver
The  detection  and  lesional  characterisation  of  cirrhosis  of
the  liver  may  be  a  problem  [26].  In  fact,  the  progression
of  cirrhosis  of  the  liver  may  induce  a  reduction  in  the  size
of  haemangiomas.  They  become  more  ﬁbrous  and  more
difﬁcult  to  recognise  radiologically  and  histologically  [26].
Capsular  retraction  may  occur  [21,26].
In  sonography,  the  dysplastic  nodule  and  hepatocel-
lular  carcinoma  may  come  in  the  form  of  a  hypere-
chogenic  nodule  similar  in  appearance  to  a  haemangioma
[24].
Due  to  liver  perfusion  disorders  related  to  the  ﬁbrosis,
the  lesional  enhancement  may  be  perturbed  in  CT-scan  [26].
The  MRI  may,  in  this  case,  be  superior,  allowing  visualisa-
tion  of  the  more  characteristic  enhancement  proﬁles  [26].
The  T2  sequences  and  diffusion-weighted  also  increase  the
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ensitivity  of  the  examination  although  the  high  intensity
ignal  on  T2-weighted  images  [17].
pecial cases
nfantile hepatic haemangiomas
omprising  almost  90%  of  the  hepatic  vascular  anomalies  in
he  child  [27], infantile  hepatic  haemangiomas  may  present
hemselves  in  the  form  of  an  asymptomatic  abdominal  mass
r  induce  serious,  possibly  life-threatening,  complications
congestive  heart  failure  due  to  the  association  with  large
rterioportal  shunts;  Kasabach-Merrit  syndrome:  coagulopa-
hy  due  to  the  intra-lesional  platelet  sequestration;  severe
ypothyroidism;  anaemia  and  haemoperitonitis  on  sponta-
eous  rupture)  [28]. The  study  by  Kassarjian  et  al.  [29],  in
 series  of  55  infantile  hepatic  haemangiomas,  found  40%  to
e  of  solitary  form  and  60%  of  multifocal  form.  Congestive
eart  failure  is  the  complication  that  determines  the  need
or  treatment  (corticoids,  embolisation  or  liver  transplant),
arried  out  for  76%  of  the  children  [29]. Although  they  do  not
eveal  an  imaging  criterion  predictive  of  death,  the  presence
f  a  shunt  (arterioportal,  arterio-venous  or  porto-venous),
resent  in  36%  of  the  children,  predisposes  a  failure  in  the
edical  treatment  [29].
epatic angiosarcoma: a rare differential
iagnosis
f  in  most  cases,  all  of  the  imaging  techniques  help  dis-
inguish  haemangiomas  from  hypervascular  metastases  and
CC,  the  differential  diagnosis  between  the  two  latter
esions  and  angiosarcoma  may  turn  out  to  be  impossible
ince  percutaneous  biopsies  are  counter-indicated  due  to
he  potentially  deadly  risk  of  haemorrhage  [30]. A  primi-
ive  rare  hepatic  sarcoma  (about  1%  of  all  primitive  hepatic
umours),  the  angiosarcoma  is  a  malignant  tumour  consisting
f  fusiform  or  pleomorphic  cells  developing  in  the  opening  of
re-existing  vascular  spaces  [2].  There  are  often  metastatic
esions  at  the  time  of  the  diagnosis,  preferentially  located
t  the  spleen  and  lungs.  Four  lesional  forms  are  observed
ttesting  either  to  multiple  nodules,  or  a predominant  volu-
inous  mass,  or  a  mixed  form  associating  a dominant  mass
nd  nodules,  or  diffuse  micronodular  inﬁltration  (Fig.  10).
n  intra-intestinal  haemorrhage  may  be  observed  leading,
n  MRI,  to  an  hyperintensity  on  T1-weighted  images  and
 liquid-liquid  level  in  T2-weighted  images  by  deposit  of
aemosiderin  [30].
858  T.  Klotz  et  al.
Figure 10. Hepatic angiosarcoma. a: Contrast-enhanced CT during arterial phase, axial section: dominant mass of segments V and VI,
early and heterogeneous enhancement; b: Contrast-enhanced CT during arterial phase, axial section: multiple associated nodular lesions
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onclusion
lthough,  in  the  vast  majority  of  cases,  the  radiological  diag-
osis  of  hepatic  haemangioma  is  clearly  established,  certain
emiological  atypies  may  make  the  diagnosis  difﬁcult.  The
resence  of  a  lesional  continuum  between  the  capillary,  cav-
rnous  and  sclerosed  haemangiomas  may  account  for  the
adiological  variants.  The  haemangioma  appears  as  an  active
ascular  lesion  in  interaction  with  its  immediate  environ-
ent  that  may  be  at  the  origin  of  arterioportal  shunts,
erilesional  zones  free  of  steatosic  inﬁltration,  focal  nodu-
ar  hyperplasias,  compressions  on  the  bile  ducts  and  hepatic
apsular  retraction.
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